26 June 2023 in Echocardiography
STSigurdur James Thorleifsson
Sigurdur James Thorleifsson
+7
Introduction and Objectives: Using existing transthoracic echocardiographic indices to quantify left ventricular wall motion abnormalities (WMAs) can be difficult due to the variations in the location of the abnormalities within the left ventricle, the quality of examinations, and the inter‐/intra‐observer variability of available indices. This study aimed to evaluate a new approach for measuring the extent of WMA by calculating the percentage of abnormal wall motion and comparing it to the wall motion score index (WMSI). The study also sought to assess inter‐ and intra‐observer variability.Methods: The study included 140 echocardiograms from 54 patients presenting with ST‐elevation myocardial infarction or Takotsubo syndrome. All patients underwent an echocardiographic examination according to a standard protocol and the images were used to measure the extent of akinesia (proportion akinesia, PrA), akinesia and hypokinesia (proportion akinesia/hypokinesia, PrAH), and WMSI. The inter‐observer variability between the two operators was analyzed. The intra‐observer analysis was performed by one observer using the same images at least 1 month after the first measurement. The agreement was analyzed using the Pearson correlation coefficient and Bland‐Altman plots.Results: Inter‐ and intra‐observer variability for PrA and PrAH were low and comparable to those for WMSI.Conclusion: PrA and PrAH are reliable and reproducible echocardiographic methods for the evaluation of left ventricular wall motion.
20 March 2026 in SSRN Electronic Journal
STSigurdur James Thorleifsson
Sigurdur James Thorleifsson
+6
BackgroundLeft ventricular diastolic dysfunction following Takotsubo syndrome (TS) and ST-elevation myocardial infarction (STEMI) is a marker of impaired myocardial relaxation and reduced ventricular compliance and is associated with adverse outcomes. We hypothesized that differences in diastolic function explain the better hemodynamic profile seen in TS compared to STEMI despite similar or more extensive cardiac systolic dysfunction.MethodsDaily echocardiographic examinations including diastolic function parameters were made in women with TS (N=69) or anterior STEMI (N=43), starting on the day of symptom onset. The primary endpoints were a set of diastolic indices at 24 hours after symptom onset. Women were also classified into diastolic subgroups based on the 2025ASE recommendations on evaluation of left ventricular diastolic function.ResultsTS and STEMI were balanced in age (69.4±11.1 versus 69.5±11.0), baseline risk factors and pre-admission cardiovascular medications. Women with TS had significantly lower S/D (p=0.05), and higher E/é-lateral (p=0.04), and LAVI (p=0.05) compared to STEMI 24 hours after admission. But there were no significant differences between the groups in diastolic grade, after 24 hours. Longitudinal analyses of diastolic parameters over the course of the study period did not reveal any pattern suggestive of systematically worse or better diastolic function in TS than STEMI. Diastolic function parameters and diastolic function grade were similar also at 30-days follow-up in both groups.ConclusionThis study is the first to prospectively evaluate left ventricular diastolic function with repeated echocardiography. TS tend to have more impaired diastolic function indices 24 hours after admission compared to STEMI.
1 January 2026 in Open Heart
Background: Both Takotsubo syndrome (TS) and ST-elevation myocardial infarction (STEMI) are conditions characterised by the acute onset of left ventricular (LV) dysfunction. While LV thrombus is a known complication of LV dysfunction, its epidemiology in these two patient groups remains poorly understood. Methods: We used data from the Stunning in Takotsubo versus Acute Myocardial Infarction (STAMI) study, which prospectively enrolled patients with TS and STEMI at Sahlgrenska University Hospital. Serial echocardiography was performed on admission and on days 1, 2, 3, 7, 14 and 30. Predictors of LV thrombus were identified using Cox regression analyses. Results: 314 patients were included; 68 with TS, 148 with anterior STEMI and 98 with non-anterior STEMI. Mean LV ejection fraction (LVEF) at admission was 39% (95% CI 35.8 to 42.2) in TS, 46.7% (95% CI 43.3 to 50.1) in anterior STEMI and 52.8% (95% CI 48.9 to 56.7) in non-anterior STEMI. LV thrombus occurred in 20 of 246 (8.1%) STEMI patients but in none of the TS patients. All but one LV thrombus was found in anterior STEMI. All LV thrombi in anterior STEMI were detected within 7 days, while the single non-anterior LV thrombus was found on day 30. All patients with LV thrombi received anticoagulation. Predictors of LV thrombus included lower LVEF and higher troponin levels. Conclusions: Despite more severe LV dysfunction in TS compared with STEMI, LV thrombus was exclusively found in STEMI patients. Almost all LV thrombi were found in anterior STEMI within the first week and showed a high-resolution rate at 30 days. Our findings highlight pathophysiological differences between these two conditions, warranting further investigation and implications for differing surveillance needs after TS and STEMI.